The legal industry has been left permanently altered from the pandemic. Five thought leaders provide their exclusive take into what these changes look like from the inside
While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.
Exclusive IAM analysis reveals how leading businesses in seven industries handled renewals at the height of the covid-19 crisis
21 May 2021
Despite advocacy of TRIPS waiver, the country’s government has expressed reluctance to bypass patent rights
18 May 2021
“Once you have taken this genie out of the bottle, it will be very hard to put it back in again,” says former USPTO head
17 May 2021
Up to 30,000 individual grants are at risk as the country’s highest court decides whether to retroactively apply a landmark ruling it handed down last week
11 May 2021
This week’s unprecedented move raises a series of worrying questions and puts in doubt the administration’s commitment to fostering innovative activity
08 May 2021
Landmark move suggests realignment in America’s domestic and international healthcare IP stance
06 May 2021
Vaccine owners may be forced to hand over trade secrets or have their patents cancelled under legislation endorsed by the upper house of the country’s Congress
04 May 2021
On World IP Day it's time to get a few things straight about where the real problems in getting jabs to those who need them really lie
26 April 2021
President Biden and other leaders are coming under pressure to agree a suspension of IP rights, but a key point has been missed
20 April 2021
Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible
13 April 2021
Unlock unlimited access to all IAM content
